

PhD Degree in Production Engineering focused on Project Management at Sao Paulo State University (UNESP), Master Degree in Science & Electrical Engineering with emphasis in Control & Industrial Automation at Federal University of Itajubá (UNIFEI), MBA at G…more ›

Pharmacist, male, 33 years old, Regulatory Manager at GSK based in Rio de Janeiro, Brazil. Currently responsible for all Branded Generics and Generics Regulatory activities of GSK in Brazil. I have been also supporting a couple of local Business Development initiatives …more ›

Médico Pesquisador e CEO do CCBR Brasil Centro de Análises e Pesquisas Clínicas há 10 anos no mercado com mais de 40 estudos multicentricos conduzidos para as grandes multinacionais. Temos unidades no Rio e S Paulo com caracteristicas de multiespecia…more ›

Vinzenz Plorer is Vice President Operations at EMS Pharma in charge of unbranded generics business, branded generics business, hospital business and international business. EMS is the leading pharmaceutical company in Brazil with around 10% market share of the total pha…more ›

I studied at Universidad Centro-Occidental “Lisandro Alvarado” (UCLA) and graduated as a physician in 1993. I obtained a specialization post degree in Internal Medicine in 1998 at the Universidad Central de Venezuela (UCV). As soon as I finished my specialization I star…more ›

Mauricio Joffily Pereira da Costa Pinheiro is graduated in Law at PUC/SP (Catholic University of São Paulo – Brazil), with specialization in Intellectual Property and Tax and post-graduating degree in business management from FGV. Mauricio is currently at the Lega…more ›

Fabio Mataveli holds a MD from the State University of Campinas (UNICAMP), a PhD in Gene Therapy from the Federal University of São Paulo (UNIFESP), a MBA in Finance from Fundação Getulio Vargas (FGV) and a Specialization in Health Economics from the Stat…more ›

Graduated in Economy at the University of São Luis, S.Paulo, post graduation in Marketing at the FGV and Business Management from Don Cabral Foundation. Broad knowledge in generics in Brazil, have been working in sales since the beginning of the generic.Participa…more ›

Derek Kosti is the Worldwide Biopharmaceutical Business Controller - International for Pfizer Inc. In this role, Derek is responsible for ensuring the integrity of financial reporting, enhancing the control environment and reviewing all collaborative arrangements relat…more ›

Odnir Finotti is the Executive President and current CEO of ProGenericos. Mr. Finotti has been working in the pharmaceutical industry for over 30 years, including 15 years as CEO for multinational companies like ASTA Medica, Schering-Plough and Mepha Brasil. Founded in…more ›

Ronaldo graduated in Biology (Genetics) in Federal University of Rio de Janeiro in 2009. Nowadays he is a PhD student from the Morphological Sciences Program of the Biomedical Sciences Institute at the same university, where he also achieved a Masters degree in 2011. Ro…more ›

João B. Calixto received degree in Biological Sciences in 1973 at the University of Brasilia and then concluded his Master Science in Pharmacology by Federal University of São Paulo, (EPM) in 1976 and this PhD in Pharmacology in 2004, at the University of S…more ›

Dr. Roberto de Araújo is a geneticist with a PhD in Molecular Biology degree from Aberdeen University, UK. Throughout his time abroad, for some 22 years, Dr. Araújo has had the opportunity to work at the very best research facilities across the globe in severa…more ›

Samuel Silva, PhD has several years of experience in the pharmaceutical research and development field. Dr. Silva Currently heads the R&D operations at Cristalia Quimica & Farmaceutica in Sao Paulo, Brazil, in this position he is responsible for providing strat…more ›

Dr Sousa earned his bachelor degree in Chemistry (1998), Masters(2000) and Doctoral in Chemistry (2003) at the Federal University of Ceará(Brazil) working with bioinorganic chemistry. In 2001, he spent time doing research at the San Francisco State University (San …more ›
The World Pharma Trials Congress LatAm is where pharma companies, trial sponsors, regional and international CROs and clinical trial sites gather to discuss clinical drug development throughout Latin America.
Join senior level attendees from international pharmas looking to obtain regulatory data for products in Latin American, to regional companies trying to optimize drug clinical development. Tap into the Latin American pharma markets by partnering with CROs and clinical trial sites.
Co-located with the Biopharma LatAm Convention, this is the leading event to attend if you’re looking for bio partnering, investment and licensing opportunities throughout Latin America.